Skip to main content
International Journal of Ophthalmology logoLink to International Journal of Ophthalmology
. 2012 Oct 18;5(5):605–608. doi: 10.3980/j.issn.2222-3959.2012.05.12

Effects of body mass index on intraocular pressure and ocular pulse amplitude

Remzi Karadag 1, Zeynel Arslanyilmaz 2, Bahri Aydin 1, Ibrahim F Hepsen 2
PMCID: PMC3484700  PMID: 23166873

Abstract

AIM

To investigate the effects of body mass index (BMI) on intraocular pressure (IOP) and ocular pulse amplitude (OPA).

METHODS

Totally 140 healthy individuals without any systemic diseases were included in the study. BMI (kg/m2) was calculated for every individual. IOP and OPA were measured with Pascal Dynamic contour tonometer (DCT). Blood pressure was also measured along with the DCT. The patients were divided into three groups according to BMI as: Group1, BMI<25; Group2, 25≤BMI<30; Group3, BMI≥30. Mean values of IOP, OPA, systolic blood pressure (SBP) and diastolic blood pressure (DBP) were used in statistical analysis.

RESULTS

In Group1, the means of IOP, OPA, were 16.8±2.3mmHg, 2.7±0.7mmHg respectively; and SBP, DBP were 120.0±6.1mmHg, and 77.4±5.6mmHg respectively. In group2, the mean IOP, OPA, SBP, and DBP were found to be 16.6±2.1mmHg, 2.4±0.7mmHg, 121.7±5.3mmHg, and 79.5±4.9mmHg respectively. In group3, the mean IOP, OPA, SBP, and DBP were found to be 17.3±1.7mmHg, 2.1±0.7mmHg, 122.4±5.7mmHg, and 79.7±5.2mmHg respectively. There were no statistically significant difference between groups in terms of IOP, SBP and DBP, while OPA values were significantly lower in group3 (P=0.001).

CONCLUSION

Decreased OPA values in individuals with higher BMI may indicate that subjects with higher BMI have lower choroidal perfusion and lower ocular blood flow.

Keywords: body mass index, choroidal perfusion, intraocular pressure, ocular pulse amplitude, obesity

INTRODUCTION

Obesity is one of the most prevalent disorders in the world. It constitute an important risk for several diseases such as type 2 diabetes, hypertension, stroke, osteoarthritis, and sleep apnea syndrome[1]. Some eye diseases like cataract[2],[3], glaucoma[4],[5], diabetic retinopathy[6], and age-related macular degeneration[7],[8] were reported to have potential relation to obesity.

In a considerable number of patients with glaucoma, progressive damage continues despite intraocular pressure (IOP) reduction with treatment[9]. Besides the increased IOP, there are several other factors associated with glaucoma progression such as neurotoxicity, reduced ocular blood flow[10]-[12], ocular vascular dysregulation[13] and changes in systemic blood pressure.[14],[15]. Obesity possesses an increased risk for both elevated IOP[16]-[18] and systemic vascular abnormalities such as hypertension and arteriosclerosis[1]. Therefore obesity may play a role in glaucoma progression through elevated IOP and vascular dysregulation. Body mass index (BMI) is one of the most specific and objective measurement to define obesity.

Dynamic contour tonometer (DCT) (Pascal tonometer, Swiss Micro technology AG, Port, Switzerland) is one of the new contact tonometers, which was designed to perform measurements independent from biomechanic features of cornea[19]. It determines systolic and diastolic IOPs, and their differences, ocular pulse amplitude (OPA)[20]. OPA indirectly shows choroidal perfusion and ocular blood flow, which were suggested to be independent risk factors for glaucoma[20]-[22].

The purpose of this study is to investigate the relationship between body mass index and IOP, OPA measured with DCT.

MATERIALS AND METHODS

Subjects

Totally 140 subjects without any known systemic diseases were included in this study. Subjects with significant ocular disease that may affect the study results were also excluded from the study. Measurements from the right eye were used for statistical analysis. The study was performed according to the ethical principles of the Helsinki Declaration and approved by the institutional ethics committee. An informed consent was taken from all the subjects involved in the study.

BMI was calculated as weight in kilograms divided by the square of height in meters (kg/m2). Subjects with BMI lower than 18.5 were labed as underweight, within the 18.5-24.9 range labeled as normal, within the 25.0-29.9 range labeled as overweight, and higher than 30.0 labeled as obese[23],[24]. Because there were a few subjects in the low weight category, subjects in underweight and normal catagory (with 24.9 and lower BMI values) were combined to constitute Group1. Subjects labeled as overweight (between 25 and 30 BMI values) formed Group2, and subjects labeled as obese (with 30 and higher BMI values) formed Group3.

Methods

IOP and OPA were measured with DCT under topical anesthesia. There is a quality grading for DCT measures. Based on this grading, score number 1 is identified as “the best,” score number 2 and 3 are identified as “acceptable,” and 4 and 5 are identified as “not acceptable”[22],[25]. The measurements of IOP and OPA were taken on the same day between 8:00 am and 11:00 am by the same ophthalmologist. Mean IOP and OPA values were calculated after three consecutive measurements. The DCT measurements with quality 1 and 2 were taken into account. All measurements were performed by the same ophthalmologist (RK). In addition, blood pressures were also measured along with the DCT as obese subjects generally have higher blood pressures than nonobese subjects.

Statistical Analysis

Due to the fact that the data distribution was not normal, a nonparametric test, Kruskal-Wallis test, was used to compare groups. In addition, Pearson correlation test was used to find out the correlations between parameters. SPSS 13.0 statistical package was used for statistical analysis. P values of less than 0.05 were considered to be statistically significant.

RESULTS

The mean age of the subjects in Group1 was 40.6±13.8 years, 43.4±12.5 years in Group 2, and 41.9±10.2 years in Group3. Data for the age, gender, IOP, OPA, BMI, systolic and diastolic blood pressure of the subjects are presented in Table 1. There was no significant statistical difference between the groups in terms of age, gender, IOP, systolic and diastolic blood pressure (P value, 0.406, 0.707, 0.124, 0.124, 0.081 respectively). Mean of OPA was the lowest in group3 and highest in Group1. There was a significant statistical difference between the groups in terms of the mean OPA value (P=0.001) (Figure 1). In addition, a negative correlation was found between the OPA and BMI values (P=0.006, r= -0.231).

Table 1. Demographic data for each group.

Group1 Group2 Group3 P value
Number of participant 48 58 34
Gender F/M 26/22 27/31 16/18 0.707
Age (year, average ±SD) 40.6±13.8 43.4±12.5 41.9±10.2 0.406
BMI (kg/m2) 22.1±2.5 27.1±1.3 34.7±3.9
IOP (mmHg, average ±SD) 16.8±2.3 16.6±2.1 17.3±1.7 0.124
OPA (mmHg, average ±SD) 2.7±0.7 2.4±0.7 2.1±0.7 0.001
SBP (mmHg, average ±SD) 120.0±6.1 121.7±5.3 122.4±5.7 0.124
DBP (mmHg, average ±SD) 77.4±5.6 79.5±4.9 79.7±5.2 0.081

BMI; Body mass index, IOP; Intraocular pressure, OPA; Ocular pulse amplitude, SBP; Systolic blood pressure, DBP; Diastolic blood pressure.

Figure 1. The values of OPA (Ocular Pulse Amplitude) measurements in BMI (Body Mass Index) groups.

Figure 1

DISCUSSION

Obesity has been shown to cause vascular endothelial[26] and autonomic[27] dysfunction. Abnormal blood flow and unstable perfusion follow after autonomic and endothelial dysfunction[5],[28],[29]. Ocular blood flow decreases in patients with glaucoma[16] and OPA indirectly shows choroidal perfusion and ocular blood flow, which were considered as independent risk factors for glaucoma[20]-[22]. We have found that OPA value was significantly lower in group3 while there was no statistically significant difference between the three groups in terms of IOP, systolic and diastolic blood pressure. This shows that ocular blood flow may also be disturbed in obese subjects and through altered ocular blood flow, as OPA decrease implies, obesity may accelerate glaucomatous damage.

Vulsteke et al[30] reported that the lower OPA value measured with dynamic contour tonometer was related to severe glaucomatous visual field defect, and defined lower OPA values as a risk factor for visual field defects. In the present study, we have found OPA value to be the lowest in group3 and the highest in group1. Therefore decreased OPA values in obese subjects may show that obese subjects with glaucoma were more liable to glaucomatous visual field defects than nonobese subjects without glaucoma.

Obesity has been reported to be an independent risk factor for high IOP and to have a positive relationship with IOP[9]-[11]. Increased intraorbital adipose tissue elevates episcleral venous pressure, and as a result, out-flow of aqueous humour is reduced. Besides, obesity increases blood viscosity through elevated blood cell count, hemoglobin and hematocrit. Therefore, resistance to out-flow increases in episcleral veins[9]-[11]. In these ways, ocular perfusion may decrease explaining the decrease of OPA in obese subjects. Furthermore, obesity is a risk factor for systemic hypertension[31]. Increased blood pressure increases ultrafiltration of aqueous humour by increasing ciliary artery pressure, and thus, IOP increases[32],[33]. In the present study, there was no difference among the groups in terms of systolic and diastolic blood pressure. Analysis of IOP values between the groups was not statistically significant.

In conclusion, although subjects with different BMI have similar IOP, OPA values were lowest in the groupwith the highest BMI. Lower OPA values in obese subjects shows a tendency toward reduced ocular perfusion in these subjects. This may increase the vulnerability of obese people to glaucomatous injury in presence of high IOP. There is a need for future studies, which would categorize patients with glaucoma based on BMI, and would evaluate this in relation to OPA, visual field loss, and optic nerve morphologic values.

REFERENCES

  • 1.Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197–1209. doi: 10.1016/S0140-6736(05)67483-1. [DOI] [PubMed] [Google Scholar]
  • 2.Leske MC, Wu SY, Hennis A, Connell AM, Hyman L, Schachat A. Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology. 1999;106(1):35–41. doi: 10.1016/s0161-6420(99)90003-9. [DOI] [PubMed] [Google Scholar]
  • 3.Kuang TM, Tsai SY, Hsu WM, Cheng CY, Liu JH, Chou P. Body mass index and age-related cataract: the Shihpai Eye Study. Arch Ophthalmol. 2005;123(8):1109–1114. doi: 10.1001/archopht.123.8.1109. [DOI] [PubMed] [Google Scholar]
  • 4.Leske MC, Connell AM, Wu SY, Hyman LG, Schachat AP. Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol. 1995;113(7):918–924. doi: 10.1001/archopht.1995.01100070092031. [DOI] [PubMed] [Google Scholar]
  • 5.Cheung N, Wong TY. Obesity and eye diseases. Surv Ophthalmol. 2007;52(2):180–195. doi: 10.1016/j.survophthal.2006.12.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Polak BC. Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study. Diabetes Care. 2002;25(8):1320–1325. doi: 10.2337/diacare.25.8.1320. [DOI] [PubMed] [Google Scholar]
  • 7.Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL., 3rd Age-Related Eye Disease Study Research Group. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology. 2005;112(4):533–539. doi: 10.1016/j.ophtha.2004.10.047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003;121(6):785–792. doi: 10.1001/archopht.121.6.785. [DOI] [PubMed] [Google Scholar]
  • 9.Gherghel D, Orgül S, Gugleta K, Flammer J. Retrobulbar blood flow in glaucoma patients with nocturnal over-dipping in systemic blood pressure. Am J Ophthalmol. 2001;132(5):641–647. doi: 10.1016/s0002-9394(01)01193-x. [DOI] [PubMed] [Google Scholar]
  • 10.Butt Z, O'Brien C, McKillop G, Aspinall P, Allan P. Color Doppler imaging in untreated high- and normal-pressure open-angle glaucoma. Invest Ophthalmol Vis Sci. 1997;38(3):690–696. [PubMed] [Google Scholar]
  • 11.Findl O, Rainer G, Dallinger S, Dorner G, Polak K, Kiss B, Georgopoulos M, Vass C, Schmetterer L. Assessment of optic disk blood flow in patients with open-angle glaucoma. Am J Ophthalmol. 2000;130(5):589–596. doi: 10.1016/s0002-9394(00)00636-x. [DOI] [PubMed] [Google Scholar]
  • 12.Rojanapongpun P, Drance SM, Morrison BJ. Ophthalmic artery flow velocity in glaucomatous and normal subjects. Br J Ophthalmol. 1993;77(1):25–29. doi: 10.1136/bjo.77.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Gherghel D, Orgül S, Gugleta K, Gekkieva M, Flammer J. Relationship between ocular perfusion pressure and retrobulbar blood flow in patients with glaucoma with progressive damage. Am J Ophthalmol. 2000;130(5):597–605. doi: 10.1016/s0002-9394(00)00766-2. [DOI] [PubMed] [Google Scholar]
  • 14.Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nevre head and ocular ischemic disorders. Am J Ophthalmol. 1994;117(5):603–624. doi: 10.1016/s0002-9394(14)70067-4. [DOI] [PubMed] [Google Scholar]
  • 15.Kaiser HJ, Flammer J, Graf T, Stümpfig D. Systemic blood pressure in glaucoma patients. Graefe's Arch Clin Exp Ophthalmol. 1993;231(12):677–680. doi: 10.1007/BF00919280. [DOI] [PubMed] [Google Scholar]
  • 16.Klein BE, Klein R, Linton KL. Intraocular pressure in an American community. The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1992;33(7):2224–2228. [PubMed] [Google Scholar]
  • 17.Wu SY, Leske MC. Associations with intraocular pressure in the Barbados Eye Study. Arch Ophthalmol. 1997;115(12):1572–1576. doi: 10.1001/archopht.1997.01100160742012. [DOI] [PubMed] [Google Scholar]
  • 18.Mori K, Ando F, Nomura H, Shimokata H. Relationship between intraocular pressure and obesity in Japan. Int J Epidemiol. 2000;29(4):661–666. doi: 10.1093/ije/29.4.661. [DOI] [PubMed] [Google Scholar]
  • 19.Kanngiesser HE, Kniestedt C, Robert YC. Dynamic contour tonometry: presentation of a new tonometer. J Glaucoma. 2005;14(5):344–350. doi: 10.1097/01.ijg.0000176936.16015.4e. [DOI] [PubMed] [Google Scholar]
  • 20.Hoffmann EM, Grus FH, Pfeiffer N. Intraocular pressure and ocular pulse amplitude using dynamic contour tonometry and contact lens tonometry. BMC Ophthalmol. 2004;4:4. doi: 10.1186/1471-2415-4-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Schwenn O, Troost R, Vogel A, Grus F, Beck S, Pfeiffer N. Ocular pulse amplitude in patients with open angle glaucoma, normal tension glaucoma, and ocular hypertension. Br J Ophthalmol. 2002;86(9):981–984. doi: 10.1136/bjo.86.9.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Pourjavan S, Boëlle PY, Detry-Morel M, De Potter P. Physiological diurnal variability and characteristics of the ocular pulse amplitude (OPA) with the dynamic contour tonometer (DCT-Pascal) Int Ophthalmol. 2007;27(6):357–360. doi: 10.1007/s10792-007-9161-7. [DOI] [PubMed] [Google Scholar]
  • 23.Tzamaloukas AH, Murata GH, Hoffman RM, Schmidt DW, Hill JE, Leger A, Macdonald L, Caswell C, Janis L, White RE. Classification of the degree of obesity by body mass index or by deviation from ideal weight. JPEN J Parenter Enteral Nutr. 2003;27(5):340–348. doi: 10.1177/0148607103027005340. [DOI] [PubMed] [Google Scholar]
  • 24.Keskin S, Sayalı E, Temeloglu E. Obesity and Inflammation. Turkiye Klinikleri J Med Sci. 2005;25(5):636–641. [Google Scholar]
  • 25.Karadag R, Keskin UC, Koktener A, Selcoki Y, Hepsen IF, Kanbay M. Ocular pulse amplitude and retrobulbar blood flow change in dipper and non-dipper individuals. Eye. 2011;25(6):762–766. doi: 10.1038/eye.2011.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Yudkin JS, Eringa E, Stehouwer CD. “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet. 2005;365(9473):1817–1820. doi: 10.1016/S0140-6736(05)66585-3. [DOI] [PubMed] [Google Scholar]
  • 27.Lim HS, MacFadyen RJ, Lip GY. Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart. Arch Intern Med. 2004;164(16):1737–1748. doi: 10.1001/archinte.164.16.1737. [DOI] [PubMed] [Google Scholar]
  • 28.Broadway DC, Drance SM. Glaucoma and vasospasm. Br J Ophthalmol. 1998;82(8):862–870. doi: 10.1136/bjo.82.8.862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Grieshaber MC, Flammer J. Blood flow in glaucoma. Curr Opin Ophthalmol. 2005;16(2):79–83. doi: 10.1097/01.icu.0000156134.38495.0b. [DOI] [PubMed] [Google Scholar]
  • 30.Vulsteke C, Stalmans I, Fieuws S, Zeyen T. Correlation between ocular pulse amplitude measured by dynamic contour tonometer and visual field defects. Graefes Arch Clin Exp Ophthalmol. 2008;246(4):559–565. doi: 10.1007/s00417-007-0706-2. [DOI] [PubMed] [Google Scholar]
  • 31.Nyamdorj R, Qiao Q, Söderberg S, Pitkäniemi J, Zimmet P, Shaw J, Alberti G, Nan H, Uusitalo U, Pauvaday V, Chitson P, Tuomilehto J. Comparison of body mass index with waist circumference, waist-to-hip ratio, and waist-to-stature ratio as a predictor of hypertension incidence in Mauritius. J Hypertens. 2008;26(5):866–870. doi: 10.1097/HJH.0b013e3282f624b7. [DOI] [PubMed] [Google Scholar]
  • 32.Colton T, Ederer F. The distribution of intraocular pressures in the general population. Surv Ophthalmol. 1980;25(3):123–129. doi: 10.1016/0039-6257(80)90086-7. [DOI] [PubMed] [Google Scholar]
  • 33.Shiose Y. The aging effect on intraocular pressure in an apparently normal population. Arch Ophthalmol. 1984;102(6):883–887. doi: 10.1001/archopht.1984.01040030703023. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Ophthalmology are provided here courtesy of Press of International Journal of Ophthalmology

RESOURCES